AdaptHealth Reports Q4 EPS $0.27, Misses Estimates and Issues 2026 Guidance
AdaptHealth reported Q4 EPS of $0.27, missing the $0.34 consensus and down from $0.39 a year earlier. The company announced full-year 2025 results and issued preliminary guidance for 2026.
1. Q4 Earnings Shortfall
AdaptHealth reported Q4 EPS of $0.27, below the $0.34 consensus and declining from $0.39 in the prior year.
2. 2026 Guidance Issued
Alongside its full-year 2025 results, AdaptHealth provided preliminary guidance for 2026 but did not disclose expected revenue or earnings targets.
Related News
VBCH
Vanguard’s BondBuilder Suite Amasses $242M in Two Months, Fuels $70B ETF Segment
VBCH•
STEL
Stellar Bancorp Declares $0.15 Quarterly Dividend Payable June 26
STEL•
NVDA
Nvidia posts $81.6bn Q1 revenue, raises dividend 25-fold and authorizes $80bn buyback
NVDA•
AMD
Chip Rally Boosts AMD as Nvidia Forecasts $91B Sales and $80B Buybacks
AMD•
NBTX
Nanobiotix Halts Trading to Finalize €75 M Follow-On Offering Pricing
NBTX•
Sources
FZB